EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Blood-Labyrinth Barrier: Non-Invasive Delivery Strategies for Inner Ear Drug Delivery

Zhangyi Yi iD, Xiaoying Wang, Ge Yin iD, Yu Sun iD

Pharmaceutics · 07.04.2025 · 17 (4) · 482

DOI: 10.3390/pharmaceutics17040482 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 07.04.2025. Verfasst von Zhangyi Yi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Foundation for Innovative Research Groups of Hubei Province, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The inner ear is a relatively isolated organ, protected by the blood-labyrinth barrier (BLB). This barrier creates a unique lymphatic fluid environment within the inner ear, maintaining a stable physiological state essential for the mechano-electrical transduction process in the inner ear hair cells while simultaneously restricting most drugs from entering the lymphatic fluid. Under pathological conditions, dysfunction of the stria vascularis and disruption in barrier structure can lead to temporary or permanent hearing impairment. This review describes the structure and function of the BLB, along with recent advancements in modeling and protective studies related to the BLB. The review emphasizes some newly developed non-invasive inner ear drug delivery strategies, including ultrasound therapy assisted by microbubbles, inner ear-targeting peptides, sound therapy, and the route of administration of the cerebrospinal fluid conduit. We argue that some intrinsic properties of the BLB can be strategically utilized for effective inner ear drug delivery.

Schlagwörter

Stichwörter der Autor:innen

blood-labyrinth barriercochleardrug deliveryhearingstria vascularis

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Institute of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Hubei Province Clinic Research Center for Deafness and Vertigo, Wuhan 430022, China.

ORCID-Profile: Zhangyi Yi, Ge Yin, Yu Sun

Förderung

  • National Natural Science Foundation of China
  • Foundation for Innovative Research Groups of Hubei Province
  • National Key Research and Development Program of China
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Yi, Z., Wang, X., Yin, G., & Sun, Y. (2025). The Blood-Labyrinth Barrier: Non-Invasive Delivery Strategies for Inner Ear Drug Delivery. Pharmaceutics, 17(4), 482. https://doi.org/10.3390/pharmaceutics17040482

Vancouver

Yi Z, Wang X, Yin G, Sun Y. The Blood-Labyrinth Barrier: Non-Invasive Delivery Strategies for Inner Ear Drug Delivery. Pharmaceutics. 2025;17(4):482. doi:10.3390/pharmaceutics17040482

BibTeX
@article{Yi2025,
  author = {Yi, Zhangyi and Wang, Xiaoying and Yin, Ge and Sun, Yu},
  title = {The Blood-Labyrinth Barrier: Non-Invasive Delivery Strategies for Inner Ear Drug Delivery},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {4},
  pages = {482},
  doi = {10.3390/pharmaceutics17040482}
}
Kostenlos starten →